TLDR
- A Coinbase shareholder filed a derivative lawsuit against senior executives and board members over alleged compliance failures.
- The complaint claims company leaders failed to properly oversee regulatory and disclosure obligations after the 2021 listing.
- The lawsuit names CEO Brian Armstrong and other top executives as defendants.
- The filing cites a 100 million dollar settlement with New York regulators over anti-money laundering shortcomings.
- The complaint also references a 5 million dollar penalty from New Jersey authorities over unregistered securities allegations.
A Coinbase shareholder has filed a derivative lawsuit against several top executives and board members over alleged compliance failures. The complaint claims leaders failed to oversee regulatory obligations after the company’s 2021 public listing. The case seeks damages for Coinbase and demands governance reforms and compensation clawbacks.
Coinbase Faces Derivative Lawsuit Over Compliance Oversight
Shareholder Kevin Meehan filed the complaint in the U.S. District Court for the District of New Jersey. He brought the action on behalf of Coinbase against senior executives and directors. The lawsuit targets CEO Brian Armstrong, co-founder Fred Ehrsam, chief legal officer Paul Grewal, and chief financial officer Alesia Haas.
The complaint alleges the defendants breached fiduciary duties and abused control. It claims they made misleading statements after Coinbase’s April 2021 direct listing. The filing states they failed to disclose regulatory compliance risks during that period. It argues weak internal oversight allowed compliance deficiencies to continue. As a result, the company faced regulatory investigations and enforcement actions.
Meehan asserts that internal controls did not meet required standards. He states that executives did not correct compliance gaps on time. The lawsuit seeks damages on behalf of Coinbase rather than individual shareholders. It also requests changes to the company’s corporate governance structure.
The complaint calls for the clawback of compensation and profits earned during the alleged misconduct. It claims insiders received financial benefits while compliance issues persisted. The filing requests a jury trial to resolve the claims.
Regulatory Settlements and Penalties Add to Legal Pressure on Coinbase
The lawsuit references a $100 million settlement reached in early 2023. Coinbase agreed to resolve allegations with the New York State Department of Financial Services. Regulators cited shortcomings in the company’s anti-money laundering program.
Under that agreement, Coinbase committed to improving its compliance systems. The settlement required both monetary penalties and corrective measures. The complaint argues that these actions reflect prior oversight failures.
In a separate matter, Coinbase faced a $5 million penalty from the New Jersey Bureau of Securities. Authorities linked the penalty to allegations involving unregistered securities listings. The lawsuit cites this action as further evidence of compliance weaknesses.
The filing states that these enforcement actions harmed the company financially. It claims leadership failed to prevent foreseeable regulatory risks. Therefore, the plaintiff seeks corporate reforms and financial recovery for Coinbase.
Separate Delaware Case Targets Alleged Insider Trading
Coinbase and its leadership also face a separate shareholder lawsuit in Delaware. Earlier this year, a judge in the Delaware Court of Chancery allowed that case to proceed. The court reviewed claims of insider trading linked to the 2021 public listing.
That lawsuit names Brian Armstrong and board member Marc Andreessen. Plaintiffs allege insiders sold shares using nonpublic information. They claim those sales helped avoid potential losses exceeding $1 billion.
The New Jersey derivative action stands apart from the Delaware case. However, both lawsuits focus on events surrounding Coinbase’s public listing. The New Jersey complaint seeks damages for the company and demands governance changes. The court has not yet scheduled a trial date for the New Jersey case.





